View Older Stories View More Recent Stories
-
Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Day One Biopharmaceutica Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Apogee Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Cogent Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ALPINE IMMUNE SCIENCES, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CureVac N.V. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Gracell Biotechnologies Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Harpoon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CHIMERIX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ImmunoGen, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A HilleVax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Adagio Medical to Go Public via Merger with ARYA Sciences Acquisition Corp IV (ARYD)
-
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
-
Form SC 13D/A PepGen Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
-
Form SC 13D/A Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Corbus Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Mineralys Therapeutics (MLYS) Enters $120M Private Placement Financing at $13.50/sh
-
Tenaya Therapeutics (TNYA) Prices 8.89M Share Offering at $4.50/sh
-
Mineralys Therapeutics Announces $120 Million Private Placement Financing
-
Tenaya Therapeutics Announces Pricing of Underwritten Offering
-
PepGen (PEPG) Prices 7.53M Share Offering at $10.635/sh
-
PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
-
Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
-
Tyra Biosciences (TYRA) Announces $200M Private Placement
-
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
-
Form SC 13G Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
